CompletedNCT00845273
Long-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration
Phase not reported · 3,538 planned enrolment
- Countries listed
- 0
- Registry update
- October 2, 2015
Source-linked trial list
The registrations behind this number.
Verify the exact trial registrations behind a company, intervention, programme or topic count.
Exact trial list
7 matching trial registrations
- Intervention pegaptanib sodium
Showing 1–7 of 7. Every record below meets all the filters shown above.
CompletedNCT00858208
Efficacy And Safety Of Macugen In Patients With Neovascular AMD In Routine Clinical Practice.
Phase not reported · 86 planned enrolment
- Countries listed
- 1
- Registry update
- April 11, 2012
CompletedNCT00239928
Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration
PHASE2 · 61 planned enrolment
- Countries listed
- 1
- Registry update
- May 12, 2011
CompletedNCT00150202
Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)
PHASE3 · 90 planned enrolment
- Countries listed
- 1
- Registry update
- May 7, 2007
TerminatedNCT00312351
A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD)
PHASE4 · 262 planned enrolment
- Countries listed
- 1
- Registry update
- January 15, 2007
CompletedNCT00321997
A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD.
PHASE2 · PHASE3 · 540 planned enrolment
- Countries listed
- 0
- Registry update
- May 4, 2006
CompletedNCT00088192
Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)
Phase not reported · planned enrolment not reported
- Countries listed
- 1
- Registry update
- August 30, 2005